| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |